Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.

Autor: Zhao, Houli1,2,3 (AUTHOR), Wei, Jieping1,2,3 (AUTHOR), Wei, Guoqing1,2,3 (AUTHOR), Luo, Yi1,2,3 (AUTHOR), Shi, Jimin1,2,3 (AUTHOR), Cui, Qu4 (AUTHOR), Zhao, Mingfeng5 (AUTHOR), Liang, Aibin6 (AUTHOR), Zhang, Qing7 (AUTHOR), Yang, Jianmin8 (AUTHOR), Li, Xin9 (AUTHOR), Chen, Jing10 (AUTHOR), Song, Xianmin11 (AUTHOR), Jing, Hongmei12 (AUTHOR), Li, Yuhua13 (AUTHOR), Hao, Siguo14 (AUTHOR), Wu, Wenjun1,2,3 (AUTHOR), Tan, Yamin1,2,3 (AUTHOR), Yu, Jian1,2,3 (AUTHOR), Zhao, Yanmin1,2,3 (AUTHOR)
Zdroj: Journal of Hematology & Oncology. 5/4/2020, Vol. 13 Issue 1, p1-13. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje